How La-Z-Boy’s Soft Q3 Profit, Tariff Risks And Outlook Update At La-Z-Boy (LZB) Has Changed Its Investment Story

How La-Z-Boy’s Soft Q3 Profit, Tariff Risks And Outlook Update At La-Z-Boy (LZB) Has Changed Its Investment Story

Simply Wall St

Thu, February 26, 2026 at 4:11 PM GMT+9 3 min read

In this article:

LZB

+1.81%

In February 2026, La-Z-Boy reported third-quarter fiscal 2026 results showing slightly higher sales of US$541.59 million but lower net income of US$21.65 million year-on-year, reaffirmed its quarterly dividend of US$0.242 per share, and guided fourth-quarter sales to US$560 million–US$580 million.
These updates came as management flagged ongoing demand challenges and fresh trade uncertainty from new global tariffs, highlighting how external pressures and consumer softness are weighing on the furniture maker’s operations and outlook.
We’ll now examine how La-Z-Boy’s cautious demand commentary and tariff exposure may influence the existing investment narrative around growth and margins.

Capitalize on the AI infrastructure supercycle with our selection of the 33 best ‘picks and shovels’ of the AI gold rush converting record-breaking demand into massive cash flow.

La-Z-Boy Investment Narrative Recap

To own La Z-Boy, you need to be comfortable with a slower growing, income oriented furniture business that is leaning on retail expansion and operational efficiency to support earnings. The latest quarter’s higher sales but lower net income, alongside demand headwinds and new global tariffs, keeps the core near term catalyst focused on margin stabilization, while the biggest current risk is that weak traffic and discounting pressure profitability for longer than expected.

Against that backdrop, the company’s reaffirmed quarterly dividend of US$0.242 per share stands out. It signals management’s willingness to keep returning cash to shareholders even as earnings have softened, which matters for anyone whose thesis leans on income and capital returns rather than rapid growth. How comfortably that dividend sits against ongoing margin pressure and tariff related cost risk is likely to be front of mind for many investors.

Yet beneath the reassuring dividend, there is growing uncertainty around how much further margin pressure and tariff related costs might go that investors should be aware of…

Read the full narrative on La-Z-Boy (it’s free!)

La-Z-Boy’s narrative projects $2.3 billion revenue and $126.2 million earnings by 2028. This requires 3.0% yearly revenue growth and about a $34.6 million earnings increase from $91.6 million today.

Uncover how La-Z-Boy’s forecasts yield a $44.50 fair value, a 24% upside to its current price.

Exploring Other Perspectives

LZB 1-Year Stock Price Chart

The most cautious analysts were already assuming only about 3 percent annual revenue growth and earnings of roughly US$126.5 million by 2028, so if you are weighing this latest demand softness and tariff shock, it is worth asking whether their more pessimistic view on long term growth and margin resilience still feels too harsh or suddenly a bit closer to home.

Story Continues  

Explore 5 other fair value estimates on La-Z-Boy - why the stock might be worth as much as 38% more than the current price!

Form Your Own Verdict

Don’t just follow the ticker - dig into the data and build a conviction that’s truly your own.

A great starting point for your La-Z-Boy research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
Our free La-Z-Boy research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate La-Z-Boy's overall financial health at a glance.

Ready For A Different Approach?

Our top stock finds are flying under the radar-for now. Get in early:

The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Uncover the next big thing with 30 elite penny stocks that balance risk and reward.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include LZB.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin